Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2385371
Max Phase: Preclinical
Molecular Formula: C25H28N2
Molecular Weight: 356.51
Molecule Type: Small molecule
Associated Items:
ID: ALA2385371
Max Phase: Preclinical
Molecular Formula: C25H28N2
Molecular Weight: 356.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN(C(c2ccccc2)c2ccccc2)[C@H](Cc2ccccc2)CN1
Standard InChI: InChI=1S/C25H28N2/c1-20-19-27(24(18-26-20)17-21-11-5-2-6-12-21)25(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-26H,17-19H2,1H3/t20-,24-/m1/s1
Standard InChI Key: YMPROSRVUQJLNK-HYBUGGRVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.51 | Molecular Weight (Monoisotopic): 356.2252 | AlogP: 4.68 | #Rotatable Bonds: 5 |
Polar Surface Area: 15.27 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.69 | CX LogP: 5.65 | CX LogD: 3.39 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -0.12 |
1. Borzenko A, Pajouhesh H, Morrison JL, Tringham E, Snutch TP, Schafer LL.. (2013) Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers., 23 (11): [PMID:23639535] [10.1016/j.bmcl.2013.03.114] |
Source(1):